Quantcast
Last updated on April 17, 2014 at 9:28 EDT

Latest The Texas Heart Institute Stories

2010-09-14 08:00:00

SAN DIEGO, Sept. 14 /PRNewswire/ -- The 14th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) will feature a discussion titled "Latest Developments in Stem Cell and Gene Therapy in Heart Failure" which includes a presentation by Dr. Roger Hajjar, Director of the Cardiovascular Research Institute, one of the 12 translational science institutes at The Mount Sinai Medical Center in New York. Dr. Hajjar's discussion will focus on the injection of a gene into patients...

2010-05-27 14:54:33

A state-of-the-art heart pump recently approved for use in end-stage cardiac patients has a significantly lower risk for infection than an earlier model of the device, according to researchers at Henry Ford Hospital in Detroit. Known as a left ventricular assist device, the newest version of the HeartMate is much smaller than the first and uses a tiny turbine with synthetic ruby bearings, lubricated by the blood itself, to continually push blood through the body. Its predecessor is larger,...

2010-04-09 09:11:10

University of Utah heart surgeon implants VAD in Idaho man as part of national clinical trial After receiving only the fourth U.S. implant of a new-generation, Utah-made ventricular assist (VAD ) device, an Idaho man with heart failure is looking forward to resuming an active life following an operation on March 17 at University of Utah Hospital. Douglas Wiley, Kuna, Idaho, received the Levacorâ“ž¢ VAD as part of national clinical trial under way at the University...

2010-03-10 17:00:00

HOUSTON, March 10 /PRNewswire-USNewswire/ -- Charles D. Fraser, Jr., M.D., an internationally recognized leader in pediatric and congenital heart surgery, has been appointed surgeon-in-chief at Texas Children's Hospital in Houston, effective July 1. He will lead a team of more than 100 surgeons representing multiple pediatric surgical subspecialties at one of the nation's largest children's hospitals. (Read a biography and view a slideshow of Dr. Fraser). (Photo:...

2010-01-21 14:00:00

WAYNE, N.J., Jan. 21 /PRNewswire/ -- MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, announced today that it will a host an educational symposium featuring leading cardiovascular surgeons who will discuss the critical issues in caring for today's cardiovascular surgery patients. The event will take place on Sunday, January 24, during the Society of Thoracic Surgeons' 46th Annual Meeting in Fort Lauderdale, Fla. "This symposium is an extension of our...

2010-01-20 12:34:00

Device Provides Support for Those Who Are Not Acceptable Transplant Candidates SILVER SPRING, Md., Jan. 20 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the HeartMate II, a continuous-flow, left ventricular assist system as a support for severe heart failure patients who are not acceptable candidates for heart transplantation. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) The HeartMate II is already FDA-approved for use in patients...

2009-10-16 05:06:00

BELGRADE, Serbia, October 16 /PRNewswire/ -- - Clinical Trial Designed to Evaluate the Ability of Cardio3Biosciences' C-Cure(R) to Restore Heart Function Clinical Center of Serbia, Institute for Cardiovascular Diseases today announced that it has treated its first patient with a revolutionary cell-based therapy for heart failure. The patient is participating in an international trial of C-Cure(R), a second generation cell therapy developed by Cardio3 BioSciences, a leading...

2009-08-20 16:30:00

FRAMINGHAM, Mass. and SYDNEY, Aug. 20 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR - ASX: HIN) today announced that HeartWare has surpassed 50 implants in the United States under its ADVANCE Clinical Trial, marking an important early enrollment milestone. The 50th implant in the US was performed last week at the Texas Heart Institute in Houston, Texas by O.H. Frazier, MD a distinguished surgeon, scientist, and academician renowned for his research and development...

2009-07-22 09:00:00

DALLAS, July 22 /PRNewswire-USNewswire/ -- Texas Health Presbyterian Hospital Dallas has been recognized by the American Heart Association for providing quality, evidence-based care for coronary artery disease and heart failure. "This is another example of the dedication and commitment in providing stellar quality heart and vascular care to the Dallas community by physicians, nursing, allied health professionals and administration," said Jon Gardner, administrative director of the Heart...

2009-07-07 16:16:47

Structural cardiovascular abnormalities present at birth are the leading cause of heart failure in children. Nearly half a million children in the United States have structural heart problems ranging in severity from relatively simple issues, such as small holes between chambers of the heart, to very severe malformations, including complete absence of one or more chambers or valves.The July issue of the journal Pediatric Cardiology focuses on a recent meeting of pediatric cardiology experts...